Health Trials

Locally Advanced, Recurrent or Metastatic Malignancies

2

Review clinical trials related to Locally Advanced, Recurrent or Metastatic Malignancies. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors

This study was an open-label phase Ⅱ study to evaluate the safety and efficacy of SSGJ-705 Monotherapy and Combination Therapy in patients with advanced HER2-Expressing Solid Tumors.

Participants needed: 340
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Shenyang Sunshine Pharmaceutical Co., LTD.Updated: Aug 3, 2025Locations: 1
Eligibility criteria

Males and/or females over age 18. [+4]

Any remaining adverse events (AEs) > grade 1 from prior anti-tumor treatment as... [+4]

Read more
Status: Recruiting

A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients with Advanced Malignant Tumors

This study was an open-label phase I study to evaluate the safety, tolerability, PK profile and potential efficacy of SSGJ-705 as a single agent in patients with advanced malignancies.

Participants needed: 180
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.Updated: Oct 18, 2024Locations: 1
Eligibility criteria

Males and/or females over age 18 [+5]

Any remaining AEs > grade 1 from prior anti-tumor treatment as per CTCAE v5. 0,... [+5]

Read more